The fall is dominated by apple and pumpkin spice flavors, and it's time for blueberry flavors to take over the summer, ...
You're never too far from your nearest coffee shop, but if you're looking to support the highest-quality, locally-owned spots ...
Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all ...
Create a Table in Notepad using the Formatting toolbar Insert a Table in Notepad using the right-click menu Create a Table in Notepad using Markdown Syntax. Press the left mouse button, and the table ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results